SXTP Financials
60 Degrees Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$1.78
Market Cap
$4.56M
EPS
$-11.73
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$1.01M
Gross Profit
$223776.00
Operating Income
$-7.76M
Net Income
$-7.37M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$5.37M
Total Liabilities
$1.99M
Shareholders Equity
$3.46M
Cash & Equivalents
$1.51M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-6.85M
CapEx
$218084
Free Cash Flow
$-7.07M
Profitability Metrics
Gross Margin
44.5%
Operating Margin
-6.1%
ROE
-2.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SXTP revenue?
SXTP's most recent quarterly revenue was $1.01M. Annual revenue can be calculated by summing the four most recent quarters.
Is SXTP profitable?
SXTP reported a loss of $7.37M in the most recent quarter.
What is SXTP market cap?
SXTP has a market capitalization of $4.56M, making it a small-cap stock.
Does SXTP have debt?
View SXTP's balance sheet for debt information.
What is SXTP cash flow?
SXTP's most recent quarterly free cash flow was $-7.07M.